CMS to speed coverage for breakthrough devices

- CMS proposed steps to accelerate Medicare coverage for FDA‑designated breakthrough medical devices, aiming to shorten the gap between approval and reimbursement. - The key specific: the policy pathway is intended to align coverage timing with regulatory breakthrough status, though the announcement did not name eye‑specific devices. - The change could reduce coverage lag for novel platforms if implemented, but details on scope and timing remain limited in early reports. (techtarget.com) (insurancejournal.com)